Sign in
CompletedPhase 4

TIMELAPSE study

Key facts

Who runs it
Ziekenhuis Gelderse Vallei Stichting
Where
Netherlands1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 4
People taking part
190 people enrolled
Started
29 Oct 2024
Ended
14 Jan 2026
Type of study
Interventional
Record updated
29 October 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 27 criteriaShow less

Who can take part

  • Adults aged 18 - 85 years visiting the outpatient clinic department of neurology
  • Presence of insomnia disorder conform DSM-5, i.e. sleep problems in at least 3 nights a week, for at least 3 months with consequences for daytime functioning, the sleep problem cannot be better explained by or occurs exclusively during the course of another sleep disorder (e.g. sleep related breathing disorder, parasomnia)
  • Score of 10 or more on the lnsomnia Severity lndex (lSl)
  • Have a medical condition and/or chronic pain (> 3 months)

Who cannot take part

  • Current alcohol or drug abuse or addiction (benzodiazepine excluded)
  • Epilepsy
  • Ocular Hypertension / Glaucoma
  • Presence of a severe psychiatric disorder not in remission or adequately treated
  • Allergy for amitriptyline
  • Untreated sleep related breathing disorder
  • Family history of acute cardiac death
  • Recent myocardial infarction (within the past 90 days)
  • Angina pectoris / coronary insufficiency
  • A known diagnosis of dementia
  • History of delirium
  • Terminal illness (prognosis < 1 year)
  • Cardiac arrhythmia / blockade / Long QT syndrome / Brugada syndrome
  • Severe renal insufficiency (GFR <10) and/or severe liver dysfunction
  • Habitual night shift worker
  • Suicide risk
  • Participation in other interventional medical scientific studies
  • Current use of psychopharmaceuticals other than benzodiazepines
  • Current use of antimycotica
  • Wish to continue over-the-counter sleep aids as melatonin and medicinal cannabis
  • Use of off-label amitriptyline for insomnia in the past year
  • Being unable to follow study instructions and fill out the study questionnaires (in Dutch)
  • Pregnancy, lactation or wish to become pregnant in the coming 6 months

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main objective of the study is to determine whether low dose amitriptyline (10-20 mg) in chronic insomnia coexisting with medical conditions is as effective as CBT-I in improving subjective sleep.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Efficacy of low dose amitriptyline vs. cognitive behavioural therapy for chronic insomnia and medical comorbidity: a randomized controlled non inferiority trial.
Record updated
29 October 2024